Price $7.70 |
Market Cap
19.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
0.08
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-19.3K
|
FCF
-1.4
|
|
Op. Margin
-122.40%
|
Net Margin
-146.00%
|
ROE
378.40%
|
ROI
-440.80%
|
|
ROA
-76.00%
|
EPS Growth
72.70%
|
Current Ratio
0.7
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Omnicell Inc (OMCL) | $44.48 | - | - | 1.32B | Strong Buy |
| Pressure Biosciences Inc (PBIO) | $0.13 | - | - | 8.4M | Strong Buy |
| Chromadex Corp (CDXC) | $3.26 | - | - | 105.8M | Strong Buy |
| Cidara Therapeutics Inc (CDTX) | $11.55 | - | - | 78M | Strong Buy |
| Psychemedics Corp. (PMD) | $2.30 | - | 11.90% | 14.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
